zepbound lilly news - Search News

Zepbound, Food and Drug Administration

Hosted on MSN · 1d

Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea

Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with sleep apnea and obesity, the drugmaker said after the bell Friday.Trials of the Lilly drug found that it helped reduce the number of breathing disruptions in an average night of sleep.

USA Today · 14h

Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop selling off-brand versions of the weight-loss drugs. The FDA has issued warnings against the off-brand versions, citing safety concerns.

Contract Pharma · 18h

FDA Approves Lilly’s Zepbound for Sleep Apnea

Averaging up to 20% of weight loss, adults taking Zepbound had 25 fewer breathing interruptions each hour as they slept.

1don MSN

FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

2don MSN

Does This News From the FDA Make Eli Lilly a Buy for 2025?

In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results